Accessibility Menu
Harvard Bioscience Stock Quote

Harvard Bioscience (NASDAQ: HBIO)

$0.40
(1.3%)
+0.01
Price as of October 23, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$0.4
Daily Change
(1.3%) +$0.01
Day's Range
$0.4 - $0.42
Previous Close
$0.4
Open
$0.4
Beta
1.36
Volume
263,158
Average Volume
773,536
Market Cap
17.7M
Market Cap / Employee
$0.40M
52wk Range
$0.28 - $2.82
Revenue
-
Gross Margin
0.51%
Dividend Yield
N/A
EPS
-$1.3
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Harvard Bioscience Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
HBIO-83.4%-87.15%-33.65%-95%
S&P+14.5%+93.32%+14.09%+399%

Harvard Bioscience Company Info

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$20.45M-11.5%
Gross Profit$10.37M-12.8%
Gross Margin50.71%-0.8%
Market Cap$19.62M-84.1%
Market Cap / Employee$0.06M0.0%
Employees355-14.7%
Net Income-$2.28M22.0%
EBITDA$1.00M1708.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$7.44M83.8%
Accounts Receivable$11.94M-4.4%
Inventory22.3-11.4%

Liabilities

Q2 2025YOY Change
Long Term Debt$7.00M-80.9%
Short Term Debt$36.32M660.1%

Ratios

Q2 2025YOY Change
Return On Assets-54.93%-47.1%
Return On Invested Capital-7.01%-2.9%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$2.36M241.9%
Operating Free Cash Flow$2.45M389.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.801.410.391.32-26.45%
Price to Sales1.201.000.270.22-81.92%
Price to Tangible Book Value-26.32-20.64-6.06-4.61-90.44%
Price to Free Cash Flow TTM18.47138.8465.344.46-72.34%
Enterprise Value to EBITDA2084.7869.03405.1955.70-102.14%
Free Cash Flow Yield5.4%0.7%1.5%22.4%261.59%
Return on Equity-20.4%-18.2%-138.8%-138.4%824.10%
Total Debt$45.69M$44.50M$44.61M$43.31M4.49%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.